Related Topics News -

     
 Title only   |   Print 
     
《業績》科濟藥業中期虧損收窄至6,666萬人民幣

2026-08-18T  
科濟藥業CT1190B獲國家藥監局IND批准 治療復發/難治性大B細胞淋巴瘤

2026-08-07T  
科濟藥業CT0596獲國家藥監局IND批准 治療多發性骨髓瘤

2026-08-04T  
科濟藥業低開6.48% 配股淨籌4.62億元

2026-05-15T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.